Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia
This is a pilot study.
The aim of the investigators' study is to evaluate the effectiveness of nigella sativa seed in the treatment of dyslipidemia.
Dyslipidemia is a common risk factor for cardiovascular disease, the leading cause for morbidity and mortality among patients.
Nigella sativa is an easily available and acceptable remedy to treat dyslipidemia and at a low cost.
It is expected that by scientifically determining the effectiveness of this intervention it will lead to its widespread use.
This will provide a low cost alternative to treat dyslipidemia.
Metabolic Syndrome X
Drug: Nigella sativa seed
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia: A Randomized Controlled Trial|
- The primary end point for the trial is serum low-density lipoprotein (LDL) cholesterol concentration measured at six weeks after intervention.
- Serum total cholesterol concentrations measured at six weeks after intervention
- Serum concentrations of high-density lipoprotein (HDL) cholesterol measured at six weeks after intervention
- Serum triglyceride concentrations measured at six weeks after intervention
- Serum blood sugar concentrations measured at six weeks after intervention
- Blood pressure measured at six weeks after intervention
- Changes in ALT (SGPT) and serum creatinine after six weeks intervention
|Study Start Date:||February 2006|
|Study Completion Date:||March 2007|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00327054
|Aga Khan University|
|Karachi, Sindh, Pakistan, 74800|
|Principal Investigator:||Waris - Qidwai||Aga Khan University, Karachi|